$272 Million is the total value of Parkman Healthcare Partners LLC's 76 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 34.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $21,633,000 | +62.7% | 91,806 | +23.9% | 7.97% | +104.8% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $14,798,000 | +14.6% | 28,811 | +13.8% | 5.45% | +44.2% |
| DHR | Buy | DANAHER CORPORATION | $9,752,000 | -10.1% | 38,466 | +4.0% | 3.59% | +13.1% |
| WAT | New | WATERS CORP | $8,688,000 | – | 26,250 | +100.0% | 3.20% | – |
| ANTM | New | ELEVANCE HEALTH INC | $8,566,000 | – | 17,750 | +100.0% | 3.16% | – |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $8,343,000 | +40.7% | 85,589 | +35.4% | 3.07% | +77.1% |
| CDMO | Buy | AVID BIOSERVICES INC | $7,038,000 | -15.2% | 461,226 | +13.2% | 2.59% | +6.7% |
| ALT | Buy | ALTIMMUNE INC | $6,549,000 | +247.4% | 559,755 | +80.8% | 2.41% | +337.0% |
| IONS | New | IONIS PHARMACEUTICALS INC | $6,453,000 | – | 174,300 | +100.0% | 2.38% | – |
| CTIC | Buy | CTI BIOPHARMA CORP | $6,275,000 | +497.1% | 1,051,047 | +367.1% | 2.31% | +650.3% |
| AVTR | Buy | AVANTOR INC | $5,358,000 | +0.0% | 172,269 | +8.8% | 1.97% | +25.9% |
| New | R1 RCM INC | $4,829,000 | – | 230,413 | +100.0% | 1.78% | – | |
| CNCE | Buy | CONCERT PHARMACEUTICALS INC | $4,732,000 | +272.0% | 1,124,072 | +197.8% | 1.74% | +368.5% |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $4,339,000 | -17.8% | 171,214 | +2.3% | 1.60% | +3.4% |
| ATEC | Buy | ALPHATEC HLDGS INC | $3,425,000 | -34.1% | 523,735 | +15.9% | 1.26% | -17.1% |
| SDGR | Buy | SCHRODINGER INC | $3,228,000 | -18.4% | 122,225 | +5.5% | 1.19% | +2.8% |
| ANIP | Buy | ANI PHARMACEUTICALS INC | $3,221,000 | +6.2% | 108,559 | +0.6% | 1.19% | +33.6% |
| New | ARCELLX INC | $3,218,000 | – | 178,000 | +100.0% | 1.18% | – | |
| New | PROCEPT BIOROBOTICS CORP | $3,089,000 | – | 94,500 | +100.0% | 1.14% | – | |
| PODD | Buy | INSULET CORP | $3,027,000 | -10.3% | 13,889 | +9.6% | 1.12% | +12.9% |
| MNKD | Buy | MANNKIND CORP | $2,914,000 | +17.3% | 764,814 | +13.2% | 1.07% | +47.6% |
| PFMT | Buy | PERFORMANT FINL CORP | $2,660,000 | -10.6% | 1,011,324 | +5.7% | 0.98% | +12.5% |
| COGT | New | COGENT BIOSCIENCES INC | $2,605,000 | – | 288,750 | +100.0% | 0.96% | – |
| DXCM | Buy | DEXCOM INC | $2,596,000 | -60.2% | 34,834 | +173.5% | 0.96% | -49.9% |
| AKYA | Buy | AKOYA BIOSCIENCES INC | $2,374,000 | +43.7% | 184,785 | +22.9% | 0.87% | +81.0% |
| DAWN | New | DAY ONE BIOPHARMACEUTICALS I | $2,054,000 | – | 114,750 | +100.0% | 0.76% | – |
| Buy | IMAGO BIOSCIENCES INC | $1,974,000 | -26.7% | 147,387 | +5.5% | 0.73% | -7.7% | |
| KRMD | Buy | REPRO MED SYS INC | $1,709,000 | -11.1% | 675,434 | +0.4% | 0.63% | +11.7% |
| HAE | New | HAEMONETICS CORP MASS | $1,630,000 | – | 25,000 | +100.0% | 0.60% | – |
| New | RXSIGHT INC | $1,619,000 | – | 115,000 | +100.0% | 0.60% | – | |
| AXGN | Buy | AXOGEN INC | $1,544,000 | +50.8% | 188,494 | +46.2% | 0.57% | +89.7% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $1,527,000 | -23.1% | 21,336 | +5.5% | 0.56% | -3.3% |
| VCYT | Buy | VERACYTE INC | $1,472,000 | -12.0% | 73,966 | +22.0% | 0.54% | +10.8% |
| FULC | Buy | FULCRUM THERAPEUTICS INC | $1,287,000 | -66.9% | 262,689 | +59.7% | 0.47% | -58.3% |
| LNDC | Buy | LANDEC CORP | $1,213,000 | -9.1% | 121,618 | +5.5% | 0.45% | +14.3% |
| KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $1,208,000 | +2.8% | 124,708 | +5.5% | 0.44% | +29.4% |
| BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $1,014,000 | -59.7% | 60,426 | +5.5% | 0.37% | -49.3% |
| TKNO | Buy | ALPHA TEKNOVA INC | $1,008,000 | -38.9% | 119,997 | +0.4% | 0.37% | -23.2% |
| OPNT | Buy | OPIANT PHARMACEUTICALS INC | $907,000 | +30.1% | 75,632 | +132.3% | 0.33% | +63.7% |
| PSTV | Buy | PLUS THERAPEUTICS INC | $828,000 | -45.7% | 1,533,075 | +0.4% | 0.30% | -31.8% |
| TELA | Buy | TELA BIO INC | $764,000 | -39.5% | 108,984 | +0.4% | 0.28% | -23.8% |
| ZYME | Buy | ZYMEWORKS INC | $667,000 | -14.6% | 125,806 | +5.5% | 0.25% | +7.4% |
| TVTX | New | TRAVERE THERAPEUTICS INC | $636,000 | – | 26,250 | +100.0% | 0.23% | – |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $623,000 | -6.7% | 32,014 | +5.5% | 0.23% | +17.4% |
| PHAT | Buy | PHATHOM PHARMACEUTICALS INC | $583,000 | -34.6% | 69,135 | +5.5% | 0.22% | -17.6% |
| ALLK | Buy | ALLAKOS INC | $502,000 | -42.1% | 160,376 | +5.5% | 0.18% | -27.2% |
| LXRX | New | LEXICON PHARMACEUTICALS INC | $465,000 | – | 250,000 | +100.0% | 0.17% | – |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $367,000 | -8.5% | 26,677 | +5.5% | 0.14% | +15.4% |
| BLRX | Buy | BIOLINERX LTDsponsored ads | $365,000 | -21.2% | 285,454 | +5.5% | 0.13% | -1.5% |
| EIGR | Buy | EIGER BIOPHARMACEUTICALS INC | $332,000 | -20.0% | 52,733 | +5.5% | 0.12% | +0.8% |
| SLN | New | SILENCE THERAPEUTICS PLCads | $311,000 | – | 26,250 | +100.0% | 0.12% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 16 | Q3 2023 | 6.3% |
| ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
| XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
| NATERA INC | 16 | Q3 2023 | 3.4% |
| AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
| SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
| REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
| MANNKIND CORP | 15 | Q3 2023 | 1.6% |
| IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
| INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.